Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicology and Applied Pharmacology 360 (2018) 1-8]

Affiliations

• ¹ Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China. Electronic address: liuyanrong1984@163.com.
• ² Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
• ³ Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.
• ⁴ Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: sunrockmia@hotmail.com.
• ⁵ Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: cyang66_2001@163.com.